Table 3: Effect size analysis after intervention.
| Variable |
Cohen’s d test |
Variable |
Cohen’s d test |
| Weight (kg) |
1.13 |
C:14:0 |
0.19 |
| Waist circumference (cm) |
1.19 |
C:16:0 |
0.50 |
| Hip circumference (cm) |
0.77 |
C:16:1 (ω-9) |
0.54 |
| BMI (kg/m2) |
0.67 |
C:18:0 |
0.15 |
| Fat mass (%) |
0.74 |
C:18:1 (ω-9) |
0.19 |
| Systolic blood pressure (mmHg) |
0.11 |
C:18:2 (ω-6) |
0.30 |
| Diastolic blood pressure (mmHg) |
0.19 |
C:18:3 (ω-3) |
0.04 |
| Glucose (mmol/L) |
0.08 |
C:20:1 (ω-9) |
0.30 |
| Total cholesterol (mmol/L) |
0.32 |
C:20:3 (ω-6) |
0.11 |
| HDL-c (mmol/L) |
0.13 |
C:20:4 (ω-6) |
0.26 |
| LDL-c (mmol/L) |
0.46 |
C:20:5 (ω-3) |
0.17 |
| Triglycerides (mmol/L) |
0.11 |
C:22:6 (ω-3) |
0.37 |
| LNC-2 (ng/mL) |
0.49 |
SFA |
0.55 |
| hsCPR (mg/L) |
0.15 |
MUFAs |
0.01 |
| Adiponectin (μg/mL) |
0.51 |
PUFAs |
0.36 |
| Insulin (pmol/L) |
0.11 |
ω-6 |
0.21 |
| HOMA-IR |
0.11 |
ω-3 |
0.21 |
| C:12:0 |
0.12 |
|
|
BMI=Body mass index; HDL-c= High density lipoprotein; LDL-c=Low density lipoprotein; LNC-2= Lipocalin-2; hsCRP=High sensitivity C-reactive protein; HOMA-IR=Homeostasis model assessment insulin resistance; SFA= Saturated fatty acids; MUFAs= Monounsaturated fatty acids; PUFAs= Polyunsaturated fatty acids.